|
|
News Breaks | | | | December 6, 2012 | | 16:09 EDT |  | NVAX | Novavax' Phase I RSV vaccine data published in Vaccine
Novavax today announced that the journal Vaccine has published the company's data from its 2011 Phase I clinical trial of its respiratory syncytial virus, RSV, fusion, F,recombinant nanoparticle vaccine candidate. The paper was authored by a team of researchers and clinicians at Novavax and Dr. Pedro Piedra of Baylor College of Medicine. Findings from the trial were announced in October 2011 and presented in September by Novavax at the Respiratory Virus Symposium,RSV 2012, meeting in Santa Fe, New Mexico. | |
|
News For NVAX From The Last 14 Days Check below for free stories on NVAX the last two weeks. |
|
|
| May 20, 2013 | | 08:04 EDT | | NVAX | Flexion Therapeutics names Frederick Driscoll CFO
 Subscribe for More Information | | | May 10, 2013 | | 08:09 EDT | | NVAX | Novavax H7N9 influenza vaccine enters animal testing
Subscribe for More Information | |
|
|
|
|
|
|
